agilon health, inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
agilon health, inc. (AGL) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $2.15M, a 39.90% increase year-over-year.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $55.00K, a 19.57% increase year-over-year.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.66M, a 345.43% increase from fiscal 2024.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $372.00K, a 87.40% decline from fiscal 2023.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $2.95M, a 57.75% decline from fiscal 2022.
- agilon health, inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $6.99M, a 36.63% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.15M 10-Q · filed 2026-08-05 | $2.20M derived: sum of 3 quarters · filed 2026-08-05 | $2.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $2.15M 10-Q · filed 2026-05-06 | $2.20M derived: sum of 2 quarters · filed 2026-05-06 | $2.20M derived: sum of 3 quarters · filed 2026-05-06 | $2.27M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $55.00K derived: sum of 2 quarters · filed 2026-02-25 | $123.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.66M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $68.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.60M 10-Q · filed 2025-11-04 | $1.65M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.60M 10-Q · filed 2026-08-05 | $1.65M derived: sum of 3 quarters · filed 2026-08-05 | $1.65M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $1.53M 10-Q · filed 2026-05-06 | $1.58M derived: sum of 2 quarters · filed 2026-05-06 | $1.58M derived: sum of 3 quarters · filed 2026-05-06 | $1.58M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $46.00K derived: sum of 2 quarters · filed 2026-02-25 | $46.00K derived: sum of 3 quarters · filed 2026-02-25 | $372.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $326.00K 10-Q · filed 2025-11-04 | -$333.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $326.00K 10-Q · filed 2025-08-04 | -$333.00K derived: sum of 3 quarters · filed 2026-02-25 | $2.84M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $326.00K 10-Q · filed 2025-05-06 | -$333.00K derived: sum of 2 quarters · filed 2026-02-25 | $2.84M derived: sum of 3 quarters · filed 2026-02-25 | $2.84M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | -$659.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.52M derived: sum of 2 quarters · filed 2026-02-25 | $2.52M derived: sum of 3 quarters · filed 2026-02-25 | $2.95M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.18M derived: sum of 2 quarters · filed 2024-11-07 | $3.61M 10-Q · filed 2024-11-07 | $3.31M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $435.00K 10-Q · filed 2024-08-06 | $137.00K derived: sum of 3 quarters · filed 2025-02-25 | $137.00K derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $435.00K 10-Q · filed 2024-05-07 | $137.00K derived: sum of 2 quarters · filed 2025-02-25 | $137.00K derived: sum of 3 quarters · filed 2025-02-25 | $6.25M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | -$298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$298.00K derived: sum of 2 quarters · filed 2025-02-25 | $5.81M derived: sum of 3 quarters · filed 2025-02-25 | $6.99M 10-K · filed 2025-02-25 | $8.20M 10-K · filed 2023-03-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $6.11M derived: sum of 2 quarters · filed 2023-11-02 | $7.29M 10-Q · filed 2023-11-02 | $8.50M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $6.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $7.29M 10-Q · filed 2023-08-03 | $8.50M derived: sum of 3 quarters · filed 2024-02-27 | $11.54M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-09 | $2.39M derived: sum of 2 quarters · filed 2024-02-27 | $5.43M derived: sum of 3 quarters · filed 2024-02-27 | $5.61M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.25M derived: sum of 2 quarters · filed 2024-02-27 | $4.43M derived: sum of 3 quarters · filed 2024-02-27 | $5.12M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $3.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.22M derived: sum of 2 quarters · filed 2022-11-03 | $3.91M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $861.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $689.00K 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | $363.00K 10-K · filed 2023-03-01 | ||||
| 2019-12-31 | $1.11M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |